Ihuman Inc (IH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Ihuman Inc stock (IH) is currently trading at $1.73. Ihuman Inc PE ratio is 6.07. Ihuman Inc PS ratio (Price-to-Sales) is 0.11. Analyst consensus price target for IH is $3.86. WallStSmart rates IH as Sell.
- IH PE ratio analysis and historical PE chart
- IH PS ratio (Price-to-Sales) history and trend
- IH intrinsic value — DCF, Graham Number, EPV models
- IH stock price prediction 2025 2026 2027 2028 2029 2030
- IH fair value vs current price
- IH insider transactions and insider buying
- Is IH undervalued or overvalued?
- Ihuman Inc financial analysis — revenue, earnings, cash flow
- IH Piotroski F-Score and Altman Z-Score
- IH analyst price target and Smart Rating
Ihuman Inc
📊 No data available
Try selecting a different time range
IH Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Ihuman Inc (IH)
IH trades at a modest 4% premium above its Graham fair value of $1.97. Consider waiting for a pullback.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Ihuman Inc (IH) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Ihuman Inc (IH) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Ihuman Inc (IH) Areas to Watch (7)
Revenue declining -14.10%, a shrinking business
Earnings declining -11.10%, profits shrinking
Very thin margins with limited operational efficiency
Very low institutional interest at 0.56%
Micro-cap company with very limited liquidity and high volatility
Moderate profitability with room for improvement
Decent profitability, keeps $13 per $100 revenue
Supporting Valuation Data
Ihuman Inc (IH) Detailed Analysis Report
Overall Assessment
This company scores 42/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 2 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 2.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.11), Price/Book (0.63) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Operating Margin. Growth concerns include Revenue Growth at -14.10%, EPS Growth at -11.10%, which may limit upside. Profitability pressure is visible in Return on Equity at 11.20%, Operating Margin at 8.10%, Profit Margin at 12.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 11.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -14.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
IH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
IH's Price-to-Sales ratio of 0.11x trades 44% below its historical average of 0.19x (72th percentile). The current valuation is 96% below its historical high of 2.95x set in Nov 2020, and 165% above its historical low of 0.04x in Jul 2024. Over the past 12 months, the PS ratio has expanded from ~0.1x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Ihuman Inc (IH) · CONSUMER DEFENSIVE › EDUCATION & TRAINING SERVICES
The Big Picture
Ihuman Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 849M with 14% decline year-over-year. Profit margins of 12.5% are healthy, with room for further expansion as the business scales.
Key Findings
Debt-to-equity ratio of 0.01 indicates a conservative balance sheet with 516M in cash.
Revenue contracted 14% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Ihuman Inc push profit margins above 15% as the business scales?
Dividend sustainability with a current yield of 4.3%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor EDUCATION & TRAINING SERVICES industry trends, competitive moves, and regulatory changes that could impact Ihuman Inc.
Bottom Line
Ihuman Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 11:32:47 AM
About Ihuman Inc(IH)
NYSE
CONSUMER DEFENSIVE
EDUCATION & TRAINING SERVICES
China
iHuman Inc. provides children's entertainment products and services to individual users, educational organizations and distributors in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.